Antibody-based therapies involve the use of monoclonal antibodies designed to target specific proteins on the surface of cells. These therapies are commonly used in cancer treatment, where they can block growth signals, mark cancer cells for destruction by the immune system, or deliver cytotoxic agents directly to tumors. The specificity of monoclonal antibodies reduces the risk of damage to healthy cells.
